Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Hind D, Parkin J, Whitworth V, et al. Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation. Southampton (UK): NIHR Journals Library; 2017 May. (Health Technology Assessment, No. 21.27.)
Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation.
Show detailsA full-scale RCT based on frequentist methods is not feasible based on the trial protocol piloted in this study. Before a full-scale RCT can be conducted, further formative work is required to develop an intervention that can be delivered safely by community physiotherapists in settings that are more convenient for families of boys with DMD. If such an intervention is delivered, specialist physiotherapists must help focus clinical problems, propose related exercises and collaborate in the monitoring of intervention safety and the disease condition’s development. Although absence of parent equipoise, access to pools and the prohibition on study co-enrolment are likely to preclude a full-scale randomised trial run in the UK alone, a RCT employing one of a number of novel Bayesian designs, designed for use in rare populations, may be feasible in the future.
- Conclusions - Aquatic therapy for children with Duchenne muscular dystrophy: a p...Conclusions - Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation
- Intervention development - An intervention to improve the quality of life in chi...Intervention development - An intervention to improve the quality of life in children of parents with serious mental illness: the Young SMILES feasibility RCT
- Introduction - Prognostic models of survival in patients with advanced incurable...Introduction - Prognostic models of survival in patients with advanced incurable cancer: the PiPS2 observational study
- Introduction - Clinical effectiveness and cost-effectiveness of use of therapeut...Introduction - Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-α) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits, TNF-α-Blocker ELISA kits and Promonitor® ELISA kits] versus standard care in patients with Crohn’s disease: systematic reviews and economic modelling
- Modelling progression of kidney disease in type 2 diabetes - Optimal strategies ...Modelling progression of kidney disease in type 2 diabetes - Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment – systematic review and modelling of progression and cost-effectiveness
Your browsing activity is empty.
Activity recording is turned off.
See more...